Poly Cystic Ovarian Syndrom. Pregnancy examination and test
Conditions
Interventions
Intervention 1: Intervention group (1): 44 patients received 25 drops of Foeniculum Vulgare extract three times a day after meals for 3 months. Intervention 2: Intervention group (2): 30 patients rece
Treatment - Drugs
Intervention group (1): 44 patients received 25 drops of Foeniculum Vulgare extract three times a day after meals for 3 months
Intervention group (2): 30 patients received Metformin tablet (500 milligrams) three times a day after meals for 3 months
Sponsors
Vice Chancellor Of Research, Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Poly Cystic Ovarian Syndrome patients between 18-40 years-old; Having Body mass index between 25 to 35 kilogram/Square meters Exclusion criteria: Consuming Metformin and Foeniculum Vulgarel in the past two months; Hyperprolactimenia; Cushing's syndrome; congenital adrenal hyperplasia, thyroid disorders; liver and kidney diseases; pregnancy and athletes
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anthropometric indices such as Weight; Body Mass Index; waist and hip circumferences. Timepoint: Three months after completing treatment. Method of measurement: Observation and record.;Labrotary tests. Timepoint: Three months after completing treatment. Method of measurement: Observation and record. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improving the severity of Hirsutism. Timepoint: Three months after treatment. Method of measurement: Based on the Ferriman-Gallwey score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAthena Abedinie
Babol University of Medical Sciences
Outcome results
None listed